Jazz Pharmaceuticals plc Gain (Loss) on Disposition of Assets
Jazz Pharmaceuticals plc (JAZZ) reported Gain (Loss) on Disposition of Assets of -$39.26 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2022-11-09
- Jazz Pharmaceuticals plc gain (loss) on disposition of assets for the quarter ending 2022-09-30 was $1.56M.
- Jazz Pharmaceuticals plc gain (loss) on disposition of assets for the quarter ending 2021-09-30 was $0.00.
- Jazz Pharmaceuticals plc gain (loss) on disposition of assets for the quarter ending 2020-03-31 was -$73.00K.
- Jazz Pharmaceuticals plc gain (loss) on disposition of assets for the quarter ending 2019-12-31 was -$13.00K.
- Jazz Pharmaceuticals plc gain (loss) on disposition of assets for fiscal 2019 was -$21.00K.
- Jazz Pharmaceuticals plc gain (loss) on disposition of assets for fiscal 2018 was -$655.00K.
- Jazz Pharmaceuticals plc gain (loss) on disposition of assets for fiscal 2017 was -$473.00K.
- Jazz Pharmaceuticals plc gain (loss) on disposition of assets for fiscal 2016 was -$47.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$39.26M 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | -$40.81M 10-Q · filed 2022-08-03 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-03 | |||
| 2020-03-31 | -$73.00K 10-Q · filed 2020-05-05 | -$86.00K derived: sum of 2 quarters · filed 2020-05-05 | -$87.00K derived: sum of 3 quarters · filed 2020-05-05 | -$91.00K derived: sum of 4 quarters · filed 2020-05-05 |
| 2019-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$14.00K derived: sum of 2 quarters · filed 2020-02-25 | -$18.00K derived: sum of 3 quarters · filed 2020-02-25 | -$21.00K 10-K · filed 2020-02-25 |
| 2019-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$5.00K derived: sum of 2 quarters · filed 2019-11-05 | -$8.00K 10-Q · filed 2019-11-05 | -$11.00K derived: sum of 4 quarters · filed 2020-05-05 |
| 2019-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$7.00K 10-Q · filed 2019-08-06 | -$10.00K derived: sum of 3 quarters · filed 2020-05-05 | -$547.00K derived: sum of 4 quarters · filed 2020-05-05 |
| 2019-03-31 | -$3.00K 10-Q · filed 2020-05-05 | -$6.00K derived: sum of 2 quarters · filed 2020-05-05 | -$543.00K derived: sum of 3 quarters · filed 2020-05-05 | -$402.00K derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$540.00K derived: sum of 2 quarters · filed 2020-02-25 | -$399.00K derived: sum of 3 quarters · filed 2020-02-25 | -$655.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | -$537.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$396.00K derived: sum of 2 quarters · filed 2019-11-05 | -$652.00K 10-Q · filed 2019-11-05 | -$765.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$115.00K 10-Q · filed 2019-08-06 | -$228.00K derived: sum of 3 quarters · filed 2020-02-25 | |
| 2018-03-31 | -$256.00K 10-Q · filed 2019-05-07 | -$369.00K derived: sum of 2 quarters · filed 2020-02-25 | ||
| 2017-12-31 | -$113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$473.00K 10-K · filed 2020-02-25 | ||
| 2017-09-30 | -$360.00K 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | -$47.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |